Additionally, inhibition of the EphB4-ephrin-B2 pathway in experimental HNSCC models led to the reprogramming of the tumor immune microenvironment, suggesting that targeting this system could alter tumor ecology and reduce immune evasion (38). Here, EPHB4 is linked to head and neck squamous cell carcinoma.